Literature DB >> 15298978

Should we advise patients undergoing IVF to start a cycle leading to a day 3 or a day 5 transfer?

E M Kolibianakis1, K Zikopoulos, W Verpoest, M Camus, H Joris, A C Van Steirteghem, P Devroey.   

Abstract

BACKGROUND: The aim of this study was to compare ongoing pregnancy rates per started cycle between patients randomized at consultation to have embryo transfer either on day 3 or on day 5 of in-vitro culture.
METHODS: All patients <43 years of age for whom IVF was indicated were allowed to participate in the study (day 3 group, 234 patients; day 5 group, 226 patients). Ovarian stimulation was performed either using GnRH antagonists/recombinant FSH (rFSH) (day 3, 70.1% of patients; day 5, 72.6% of patients) or using the long GnRH agonist protocol/urinary gonadotropins (day 3, 29.9% of patients; day 5 27.4% of patients).
RESULTS: The random decision to initiate a cycle leading to day 5 as compared with a day 3 transfer was associated with a significantly lower chance of embryo cryopreservation (day 3, 61.5%; day 5, 50.4%; P<0.02). Ongoing pregnancy rate per started cycle did not differ between the two groups compared [day 3, 32.1%, 95% confidence interval (CI) 26.4-38.2%; day 5, 33.2%, 95% CI 27.3-39.5%].
CONCLUSIONS: Advising patients at consultation to initiate an IVF cycle leading to a day 5 as compared with a day 3 transfer does not appear to increase the probability of ongoing pregnancy, and is associated with a significantly lower probability of obtaining cryopreserved embryos.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15298978     DOI: 10.1093/humrep/deh447

Source DB:  PubMed          Journal:  Hum Reprod        ISSN: 0268-1161            Impact factor:   6.918


  14 in total

1.  Deposition of the spermatozoon in the human oocyte at ICSI: impact on oocyte survival, fertilization and blastocyst formation.

Authors:  A De Vos; M Abraham; N Franceus; P Haentjens; H Tournaye; G Verheyen; H Van de Velde
Journal:  J Assist Reprod Genet       Date:  2015-05-01       Impact factor: 3.412

2.  Preimplantation genetic testing with HLA matching: from counseling to birth and beyond.

Authors:  M De Rycke; A De Vos; F Belva; V Berckmoes; M Bonduelle; A Buysse; K Keymolen; I Liebaers; J Nekkebroeck; P Verdyck; W Verpoest
Journal:  J Hum Genet       Date:  2020-02-27       Impact factor: 3.172

3.  Birthweight of singletons born after blastocyst-stage or cleavage-stage transfer: analysis of a data set from three randomized controlled trials.

Authors:  Anick De Vos; Samuel Dos Santos-Ribeiro; Herman Tournaye; Greta Verheyen
Journal:  J Assist Reprod Genet       Date:  2019-12-13       Impact factor: 3.412

4.  Vitrification of blastocysts derived from fair to poor quality cleavage stage embryos can produce high pregnancy rates after warming.

Authors:  Chloë Shaw-Jackson; Evelyne Bertrand; Bénédicte Becker; Jérôme Colin; Caroline Beaudoin-Chabot; Serge Rozenberg; Candice Autin
Journal:  J Assist Reprod Genet       Date:  2013-07-10       Impact factor: 3.412

5.  The reproductive outcome of female patients with myotonic dystrophy type 1 (DM1) undergoing PGD is not affected by the size of the expanded CTG repeat tract.

Authors:  Willem Verpoest; Sara Seneca; Marjan De Rademaeker; Karen Sermon; Martine De Rycke; Michel De Vos; Patrick Haentjens; Paul Devroey; Ingeborg Liebaers
Journal:  J Assist Reprod Genet       Date:  2010-03-11       Impact factor: 3.412

Review 6.  Cleavage-stage versus blastocyst-stage embryo transfer in assisted reproductive technology.

Authors:  Demián Glujovsky; Andrea Marta Quinteiro Retamar; Cristian Roberto Alvarez Sedo; Agustín Ciapponi; Simone Cornelisse; Deborah Blake
Journal:  Cochrane Database Syst Rev       Date:  2022-05-19

7.  Elective single embryo transfer: Comparison of blastocyst and cleavage-stage embryo transfer.

Authors:  Toshihiro Kawamura; Michiko Mori; Akane Arichi; Yuko Tajima; Yasuhiro Karasawa; Kahori Suga; Sachiko Ikumi; Seika Ishikawa; Makiko Kawamura
Journal:  Reprod Med Biol       Date:  2005-07-28

Review 8.  Blastocyst transfer ameliorates live birth rate compared with cleavage-stage embryos transfer in fresh in vitro fertilization or intracytoplasmic sperm injection cycles: reviews and meta-analysis.

Authors:  Shan-Shan Wang; Hai-Xiang Sun
Journal:  Yonsei Med J       Date:  2014-04-01       Impact factor: 2.759

9.  A comparative study between cleavage stage embryo transfer at day 3 and blastocyst stage transfer at day 5 in in-vitro fertilization/intra-cytoplasmic sperm injection on clinical pregnancy rates.

Authors:  Prabhleen Kaur; M L Swarankar; Manju Maheshwari; Veena Acharya
Journal:  J Hum Reprod Sci       Date:  2014-07

10.  Preimplantation genetic diagnosis: design or too much design.

Authors:  W Verpoest
Journal:  Facts Views Vis Obgyn       Date:  2009
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.